Investigation of Siderophore–Platinum (IV) Conjugates Reveals Differing Antibacterial Activity and DNA Damage Depending on the Platinum Cargo

C Guo, KKA Wang, EM Nolan - ACS Infectious Diseases, 2024 - ACS Publications
The growing threat of bacterial infections coupled with the dwindling arsenal of effective
antibiotics has heightened the urgency for innovative strategies to combat bacterial …

Developing novel antimicrobials by combining cancer chemotherapeutics with bacterial DNA repair inhibitors

L Bernacchia, A Gupta, A Paris, AA Moores… - PLoS …, 2023 - journals.plos.org
Cancer chemotherapeutics kill rapidly dividing cells, which includes cells of the immune
system. The resulting neutropenia predisposes patients to infection, which delays treatment …

Identification of a novel DNA repair inhibitor using an in silico driven approach shows effective combinatorial activity with genotoxic agents against multidrug‐resistant …

L Bernacchia, A Paris, A Gupta, RJ Charman… - Protein …, 2024 - Wiley Online Library
Increasing antimicrobial drug resistance represents a global existential threat. Infection is a
particular problem in immunocompromised individuals, such as patients undergoing cancer …

Antibiofilm formation activity of lupinifolin isolated from Derris reticulata stems against Enterococcus faecalis

P Pulbutr, K Seelakot… - Journal of Herbmed …, 2024 - herbmedpharmacol.com
Introduction: The biofilm formation capability of Enterococcus faecalis is one of the key
virulence factors contributing to its multidrug resistance and therapeutic challenges …

Siderophore-Based Drug Repurposing of Platinum Anticancer Agents as Targeted Antibiotics and Investigation of Pt-Induced DNA Damage in Gram-Negative …

C Guo - 2023 - dspace.mit.edu
Bacterial infections are a growing threat to human health. This crisis has been exacerbated
by the overuse of broad-spectrum antibiotics, resulting in adverse consequences such as …

Combining cancer chemotherapeutics with bacterial DNA repair inhibitors to develop novel antimicrobials

L Bernacchia, A Gupta, A Paris, AA Moores, NM Kad - bioRxiv, 2023 - biorxiv.org
Cancer chemotherapeutics kill rapidly dividing cells, which includes cells of the immune
system. The resulting neutropenia predisposes patients to infection, which delays treatment …